Clinical Trial: A real-world study on Senaparib for first-line maintenance treatment in patients with newly diagnosed advanced ovarian cancer,fallopian tube cancer,or primary peritoneal cancer (China)

Posted On: 2026-08-11

China, Aug. 11 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A real-world study on Senaparib for first-line maintenance treatment in patients with newly diagnosed advanced ovarian cancer,fallopian tube cancer,or primary peritoneal cancer'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600129532

Registration Time: 2026/08/06

Type: Observational study

Primary Sponsor: The Second Affiliated Hospital of Xi' an Jiaotong University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=319768

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: A real-world study on Senaparib for first-line maintenance treatment in patients with newly diagnosed advanced ovarian cancer,fallopian tube cancer,or primary peritoneal cancer (China)